Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of PF-05082566 and rituximab in cancer
jRCT2080222841Phase 1Completed
- Start
- May 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 1 trial of utomilumab and rituximab in cancer. Started May 2015; status: completed.
02
Drugs
utomilumabrituximab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222841.